NRSNW NEUROSENSE THERAPEUTICS LTD C/W
$0.01▲ +0.00%
Healthcare
Other
Volume 5
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.01 - 0.01
% vs 50 MA
-91.76%
% vs 200 MA
–%
RSI-14
33.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.03
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.77M
COGS
–
Operating Exp
$1.77M
Operating Income
-$1.77M
EBIT
-$1.77M
Pretax Income
-$1.80M
Net Income
-$1.80M
Price & Volume History
Loading chart…
Recent News
NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
PR Newswire · Oct 19, 2026 8:25 AM ET
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
PR Newswire · Oct 13, 2026 8:30 AM ET
Neurosense Therapeutics Receives Nasdaq Listing Compliance Notice
MT Newswires · Oct 2, 2026 4:36 PM ET
NeuroSense Provides Update on Nasdaq Listing Compliance
PR Newswire · Oct 2, 2026 4:15 PM ET
NeuroSense to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
PR Newswire · Sep 28, 2026 12:43 PM ET
NeuroSense Provides Business Update and Progress for the First Half of 2026
PR Newswire · Sep 25, 2026 4:30 PM ET
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 9:00 AM ET
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
PR Newswire · Aug 31, 2026 8:45 AM ET
NeuroSense Issues CEO Letter to Shareholders
PR Newswire · Aug 13, 2026 9:30 AM ET
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
PR Newswire · Aug 6, 2026 11:29 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NRSNW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.